Crinetics Pharmaceuticals (NASDAQ:CRNX) Shares Up 5.2%

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) shot up 5.2% on Monday . The stock traded as high as $20.81 and last traded at $20.56. 223,320 shares traded hands during mid-day trading, a decline of 44% from the average session volume of 399,462 shares. The stock had previously closed at $19.54. Analyst Upgrades […]

Related Keywords

Israel ,Piper Sandler ,Dana Pizzuti ,Robertw Baird ,High Net Worth Advisory Group ,Psagot Value Holdings Ltd ,Crinetics Pharmaceuticals Company Profile ,Securities Exchange Commission ,Crinetics Pharmaceuticals Trading ,Crinetics Pharmaceuticals Inc ,Nasdaq ,Institutional Investors Weigh In On Crinetics Pharmaceuticals ,Bourgeon Capital Management ,News Ratings For Crinetics Pharmaceuticals Daily ,Crinetics Pharmaceuticals ,Group One Trading ,Great West Life Assurance Co ,Get Rating ,Lifesci Capital ,Exchange Commission ,West Life Assurance ,Net Worth Advisory Group ,Value Holdings ,Capital Management ,Crinetics Pharmaceuticals Daily ,Nasdaq Crnx ,Crnx ,Medical ,Stocks ,Technicals ,